Q2 2015
Released Aug 11, 2015, before the open
10-Q filed Aug 11, 2015, 42 days after period end · 0001144204-15-047956
Q2 2015 · 10-Q
Revenue—
Net Income-$4.25M-$4.25M N/M vs Q2 2014N/M vs Q1 2015
EPS Diluted-$0.26-$0.26 N/M vs Q2 2014N/M vs Q1 2015
Operating Income-$4,277,743N/M
Operating Cash Flowderived-$3,861,542N/M
Free Cash Flowderived-$3,863,091N/M
What the release said
The release
Same quarter
| Metric | Q2 2015 | Q2 2014 | Q2 2013 | Q2 2012 |
|---|---|---|---|---|
| Net Income | -$4.25M | -$6.97M | -$1.37M | -$61.23K |
| EPS Diluted | -$0.26 | -$0.55 | -$0.31 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Lipocine Inc. · CIK 1535955 · Engraved from SEC EDGAR